Key result
This review highlights the most important cardiovascular imaging studies published in 2018 focusing on cardiomyopathies, congenital heart diseases, valvular heart diseases, and heart failure.
Why the study?
To highlight the most important cardiovascular imaging studies published in 2018 concerning cardiomyopathies, congenital heart diseases, valvular heart diseases, and heart failure.
Provides a summary of key cardiovascular imaging studies published in 2018 regarding cardiomyopathies, congenital heart diseases, valvular heart diseases, and heart failure.
Provides a 2018 imaging reference for cardiomyopathies and heart failure; leaves open integration into current protocols pending prospective validation.
European Heart Journal - Cardiovascular Imaging was launched in 2012 as a multimodality cardiovascular imaging journal. It has gained an impressive impact factor during its first 5 years and is now established as one of the top cardiovascular journals and has become the most important cardiovascular imaging journal in Europe. The most important studies from 2018 will be highlighted in two reports. Part I of the review has focused on studies about myocardial function and risk prediction, myocardial ischaemia, and emerging techniques in cardiovascular imaging, while Part II will focus on cardiomyopathies, congenital heart diseases, valvular heart diseases, and heart failure.
No takes yet. Share an insight, caveat, or question.
Cosyns et al. (2019) conducted a review in Cardiomyopathies, congenital heart diseases, valvular heart diseases, and heart failure. This review highlights the most important cardiovascular imaging studies published in 2018 focusing on cardiomyopathies, congenital heart diseases, valvular heart diseases, and heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: